Zimmerman DH - Search Results

1

Rheumatoid arthritis vaccine therapies: perspectives and lessons from therapeutic ligand epitope antigen presentation system vaccines for models of rheumatoid arthritis.

Rosenthal KS, Mikecz K, Steiner HL 3rd, Glant TT, Finnegan A, Carambula RE, Zimmerman DH. Rosenthal KS, et al. Among authors: zimmerman dh. Expert Rev Vaccines. 2015 Jun;14(6):891-908. doi: 10.1586/14760584.2015.1026330. Epub 2015 Mar 18. Expert Rev Vaccines. 2015. PMID: 25787143 Free PMC article. Review.

2

Immunization with a LEAPS heteroconjugate containing a CTL epitope and a peptide from beta-2-microglobulin elicits a protective and DTH response to herpes simplex virus type 1.

Rosenthal KS, Mao H, Horne WI, Wright C, Zimmerman D. Rosenthal KS, et al. Vaccine. 1999 Feb 12;17(6):535-42. doi: 10.1016/s0264-410x(98)00231-x. Vaccine. 1999. PMID: 10075159

3

A modification of the epidermal scarification model of herpes simplex virus infection to achieve a reproducible and uniform progression of disease.

Goel N, Docherty JJ, Fu MM, Zimmerman DH, Rosenthal KS. Goel N, et al. Among authors: zimmerman dh. J Virol Methods. 2002 Dec;106(2):153-8. doi: 10.1016/s0166-0934(02)00160-x. J Virol Methods. 2002. PMID: 12393145

4

A L.E.A.P.S. heteroconjugate vaccine containing a T cell epitope from HSV-1 glycoprotein D elicits Th1 responses and protection.

Goel N, Rong Q, Zimmerman D, Rosenthal KS. Goel N, et al. Vaccine. 2003 Oct 1;21(27-30):4410-20. doi: 10.1016/s0264-410x(03)00429-8. Vaccine. 2003. PMID: 14505924

5

CEL-1000--a peptide with adjuvant activity for Th1 immune responses.

Charoenvit Y, Goel N, Whelan M, Rosenthal KS, Zimmerman DH. Charoenvit Y, et al. Among authors: zimmerman dh. Vaccine. 2004 Jun 23;22(19):2368-73. doi: 10.1016/j.vaccine.2003.11.062. Vaccine. 2004. PMID: 15193396

6

Ligand epitope antigen presentation system vaccines against herpes simplex virus.

Goel N, Zimmerman DH, Rosenthal KS. Goel N, et al. Among authors: zimmerman dh. Front Biosci. 2005 Jan 1;10:966-74. doi: 10.2741/1591. Print 2005 Jan 1. Front Biosci. 2005. PMID: 15569635 Review.

7

CEL-2000: A therapeutic vaccine for rheumatoid arthritis arrests disease development and alters serum cytokine/chemokine patterns in the bovine collagen type II induced arthritis in the DBA mouse model.

Zimmerman DH, Taylor P, Bendele A, Carambula R, Duzant Y, Lowe V, O'Neill SP, Talor E, Rosenthal KS. Zimmerman DH, et al. Int Immunopharmacol. 2010 Apr;10(4):412-21. doi: 10.1016/j.intimp.2009.12.016. Epub 2010 Jan 13. Int Immunopharmacol. 2010. PMID: 20074669

8

J-LEAPS vaccines initiate murine Th1 responses by activating dendritic cells.

Taylor PR, Koski GK, Paustian CC, Bailey E, Cohen PA, Moore FB, Zimmerman DH, Rosenthal KS. Taylor PR, et al. Among authors: zimmerman dh. Vaccine. 2010 Aug 2;28(34):5533-42. doi: 10.1016/j.vaccine.2010.06.043. Epub 2010 Jun 25. Vaccine. 2010. PMID: 20600501

9

LEAPS therapeutic vaccines as antigen specific suppressors of inflammation in infectious and autoimmune diseases.

Zimmerman DH, Steiner H 3rd, Carmabula R, Talor E, Rosenthal KS. Zimmerman DH, et al. J Vaccines Vaccin. 2012 Sep 20;3(5):149. doi: 10.4172/2157-7560.1000149. J Vaccines Vaccin. 2012. PMID: 23400692 Free PMC article.

10

LEAPS Vaccine Incorporating HER-2/neu Epitope Elicits Protection That Prevents and Limits Tumor Growth and Spread of Breast Cancer in a Mouse Model.

Rosenthal KS, Stone S, Koski G, Zimmerman DH. Rosenthal KS, et al. Among authors: zimmerman dh. J Immunol Res. 2017;2017:3613505. doi: 10.1155/2017/3613505. Epub 2017 Mar 26. J Immunol Res. 2017. PMID: 28459074 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

52 results

Search Page